we RestorE IMMUNE RESILIENCE
Our Treatment Employs the Language of the Immune System
to Improve Patients' Health
Targeting the Underlying Cause of Disease
Autoimmune diseases cause lifelong suffering and disability for patients and place a significant burden on families and society
Our treatment aims to support the immune system rather than suppressing it, restoring its natural resilience and providing improved safety and an opportunity for durable remission
Recent News
Drug Mechanism of Action demonstrated: Mucosal healing without immune suppression
April 2022 – A major study elucidating the mechanism of action of the IBD-asset
New PCT: Nucleic acid therapy for differential modulation of host microflora
March 2022 – WO 2022/070052 A1, a new PCT covering the effect of our
ECCO 2022
February 2022 – Alma attended ECCO 2022, the 17th congress of European Crohn’s and